NMDA Receptors Subserve Persistent Neuronal Firing during Working Memory in Dorsolateral Prefrontal Cortex

Neuron

Volumn 77, Issue 4, 2013, Pages 736-749

  Wang, Min ^a   Yang, Yang ^a   Wang, Ching Jung ^b   Gamo, Nao J ^a   Jin, Lu E ^a   Mazer, James A ^a   Morrison, John H ^b   Wang, Xiao Jing ^a,c   Arnsten, Amy F T ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MALE; MATHEMATICAL MODEL; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE POTENTIAL; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; RHESUS MONKEY; SPATIAL MEMORY; STIMULUS RESPONSE; WORKING MEMORY;

ANIMALS; BRAIN MAPPING; COMPUTER SIMULATION; MACACA MULATTA; MALE; MEMORY, SHORT-TERM; MODELS, NEUROLOGICAL; NEURONS; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84874286656     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2012.12.032     Document Type: Article

References (86)

1. Anticevic A., Gancsos M., Murray J.D., Repovs G., Driesen N.R., Ennis D.J., Niciu M.J., Morgan P.T., Surti T.S., Bloch M.H., et al. NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proc. Natl. Acad. Sci. USA 2012, 109:16720-16725.
2. Arnsten A.F.T., Wang M.J., Paspalas C.D. Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses. Neuron 2012, 76:223-239.
3. Bai L., Hof P.R., Standaert D.G., Xing Y., Nelson S.E., Young A.B., Magnusson K.R. Changes in the expression of the NR2B subunit during aging in macaque monkeys. Neurobiol. Aging 2004, 25:201-208.
4. Banerjee A., Macdonald M.L., Borgmann-Winter K.E., Hahn C.G. Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome. Brain Res. Bull. 2010, 83:132-139.
5. Barch D.M., Ceaser A. Cognition in schizophrenia: core psychological and neural mechanisms. Trends Cogn. Sci. 2012, 16:27-34.
6. Bitanihirwe B.K., Lim M.P., Kelley J.F., Kaneko T., Woo T.U. Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia. BMC Psychiatry 2009, 9:71.
7. Brunel N., Wang X.J. Effects of neuromodulation in a cortical network model of object working memory dominated by recurrent inhibition. J. Comput. Neurosci. 2001, 11:63-85.
8. Buschman T.J., Miller E.K. Top-down versus bottom-up control of attention in the prefrontal and posterior parietal cortices. Science 2007, 315:1860-1862.
9. Bussière T., Giannakopoulos P., Bouras C., Perl D.P., Morrison J.H., Hof P.R. Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9. J. Comp. Neurol. 2003, 463:281-302.
10. Bustillo J.R., Chen H., Gasparovic C., Mullins P., Caprihan A., Qualls C., Apfeldorf W., Lauriello J., Posse S. Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla. Biol. Psychiatry 2011, 69:19-27.
11. Caetano M.S., Horst N.K., Harenberg L., Liu B., Arnsten A.F.T., Laubach M. Lost in transition: aging-related changes in executive control by the medial prefrontal cortex. J. Neurosci. 2012, 32:3765-3777.
12. Cho K.K., Khibnik L., Philpot B.D., Bear M.F. The ratio of NR2A/B NMDA receptor subunits determines the qualities of ocular dominance plasticity in visual cortex. Proc. Natl. Acad. Sci. USA 2009, 106:5377-5382.
13. Compte A., Brunel N., Goldman-Rakic P.S., Wang X.J. Synaptic mechanisms and network dynamics underlying spatial working memory in a cortical network model. Cereb. Cortex 2000, 10:910-923.
14. Corlett P.R., Honey G.D., Aitken M.R., Dickinson A., Shanks D.R., Absalom A.R., Lee M.C., Pomarol-Clotet E., Murray G.K., McKenna P.J., et al. Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. Arch. Gen. Psychiatry 2006, 63:611-621.
15. Cui Y., Jin J., Zhang X.H., Xu H., Yang L., Du D., Zeng Q., Tsien J.Z., Yu H., Cao X. Forebrain NR2B overexpression facilitating the prefrontal cortex long-term potentiation and enhancing working memory function in mice. PLoS ONE 2011, 6:e20312.
16. Dalton G.L., Ma L.M., Phillips A.G., Floresco S.B. Blockade of NMDA GluN2B receptors selectively impairs behavioral flexibility but not initial discrimination learning. Psychopharmacology (Berl.) 2011, 216:525-535.
17. Dawson N., Morris B.J., Pratt J.A. Subanaesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systems. Schizophr. Bull. 2011, Published online November 22, 2011. 10.1093/schbul/sbr144.
18. Driesen N.R., Leung H.C., Calhoun V.D., Constable R.T., Gueorguieva R., Hoffman R., Skudlarski P., Goldman-Rakic P.S., Krystal J.H. Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence. Biol. Psychiatry 2008, 64:1026-1034.
19. Dumas T.C. Developmental regulation of cognitive abilities: modified composition of a molecular switch turns on associative learning. Prog. Neurobiol. 2005, 76:189-211.
20. Dumitriu D., Hao J., Hara Y., Kaufmann J., Janssen W.G., Lou W., Rapp P.R., Morrison J.H. Selective changes in thin spine density and morphology in monkey prefrontal cortex correlate with aging-related cognitive impairment. J. Neurosci. 2010, 30:7507-7515.
21. Elston G.N. Cortex, cognition and the cell: new insights into the pyramidal neuron and prefrontal function. Cereb. Cortex 2003, 13:1124-1138.
22. Fitzgerald P.J. The NMDA receptor may participate in widespread suppression of circuit level neural activity, in addition to a similarly prominent role in circuit level activation. Behav. Brain Res. 2012, 230:291-298.
23. Funahashi S., Bruce C.J., Goldman-Rakic P.S. Neuronal activity related to saccadic eye movements in the monkey's dorsolateral prefrontal cortex. J. Neurophysiol. 1991, 65:1464-1483.
24. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 2000, 57:65-73.
25. Goff D.C., Keefe R.S., Citrome L., Davy K., Krystal J.H., Large C., Thompson T.R., Volavka J., Webster E.L. Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials. J. Clin. Psychopharmacol. 2007, 27:582-589.
26. Goldman-Rakic P.S. Cellular basis of working memory. Neuron 1995, 14:477-485.
27. Homayoun H., Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J. Neurosci. 2007, 27:11496-11500.
28. Honey R.A., Honey G.D., O'Loughlin C., Sharar S.R., Kumaran D., Bullmore E.T., Menon D.K., Donovan T., Lupson V.C., Bisbrown-Chippendale R., Fletcher P.C. Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an FMRI study. Neuropsychopharmacology 2004, 29:1203-1214.
29. Jackson M.E., Homayoun H., Moghaddam B. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc. Natl. Acad. Sci. USA 2004, 101:8467-8472.
30. Janssen W.G., Vissavajjhala P., Andrews G., Moran T., Hof P.R., Morrison J.H. Cellular and synaptic distribution of NR2A and NR2B in macaque monkey and rat hippocampus as visualized with subunit-specific monoclonal antibodies. Exp. Neurol. 2005, 191(Suppl 1):S28-S44.
31. Javitt D.C. Glutamatergic theories of schizophrenia. Isr. J. Psychiatry Relat. Sci. 2010, 47:4-16.
32. Jentsch J.D., Elsworth J.D., Redmond D.E.J., Roth R.H. Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966. J. Neurosci. 1997, 17:1769-1775.
33. Kantrowitz J., Javitt D.C. Glutamatergic transmission in schizophrenia: from basic research to clinical practice. Curr. Opin. Psychiatry 2012, 25:96-102.
34. Keedy S.K., Ebens C.L., Keshavan M.S., Sweeney J.A. Functional magnetic resonance imaging studies of eye movements in first episode schizophrenia: smooth pursuit, visually guided saccades and the oculomotor delayed response task. Psychiatry Res. 2006, 146:199-211.
35. Kim S., Hwang J., Lee D. Prefrontal coding of temporally discounted values during intertemporal choice. Neuron 2008, 59:161-172.
36. Kristiansen L.V., Bakir B., Haroutunian V., Meador-Woodruff J.H. Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia. Schizophr. Res. 2010, 119:198-209.
37. Kristiansen L.V., Patel S.A., Haroutunian V.H., Meador-Woodruff J.H. Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia. Synapse 2010, 64:495-502.
38. Kritzer M.F., Goldman-Rakic P.S. Intrinsic circuit organization of the major layers and sublayers of the dorsolateral prefrontal cortex in the rhesus monkey. J. Comp. Neurol. 1995, 359:131-143.
39. Krystal J.H., Abi-Saab W., Perry E., D'Souza D.C., Liu N., Gueorguieva R., McDougall L., Hunsberger T., Belger A., Levine L., Breier A. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology (Berl.) 2005, 179:303-309.
40. Krystal J.H., D'Souza D.C., Mathalon D., Perry E., Belger A., Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl.) 2003, 169:215-233.
41. Kurup P., Zhang Y., Xu J., Venkitaramani D.V., Haroutunian V., Greengard P., Nairn A.C., Lombroso P.J. Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61. J. Neurosci. 2010, 30:5948-5957.
42. Lewis D.A., Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch. Neurol. 2006, 63:1372-1376.
43. Li N., Lee B.T., Liu R.J., Banasr M., Dwyer J.M., Iwata M., Li X.Y., Aghajanian G.K., Duman R.S. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329:959-964.
44. Lidow M.S., Wang F., Cao Y., Goldman-Rakic P.S. Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex. Synapse 1998, 28:10-20.
45. Lieberman J.A., Papadakis K., Csernansky J., Litman R., Volavka J., Jia X.D., Gage A. A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia. Neuropsychopharmacology 2009, 34:1322-1329. MEM-MD-29 Study Group.
46. Linn G.S., O'Keeffe R.T., Schroeder C.E., Lifshitz K., Javitt D.C. Behavioral effects of chronic phencyclidine in monkeys. Neuroreport 1999, 10:2789-2793.
47. Lisman J.E., Fellous J.M., Wang X.-J. A role for NMDA-receptor channels in working memory. Nat. Neurosci. 1998, 1:273-275.
48. Liu Y., Wong T.P., Aarts M., Rooyakkers A., Liu L., Lai T.W., Wu D.C., Lu J., Tymianski M., Craig A.M., Wang Y.T. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 2007, 27:2846-2857.
49. Lo C.C., Boucher L., Paré M., Schall J.D., Wang X.J. Proactive inhibitory control and attractor dynamics in countermanding action: a spiking neural circuit model. J. Neurosci. 2009, 29:9059-9071.
50. Lüscher C., Malenka R.C. NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD). Cold Spring Harb. Perspect. Biol. 2012, 4:a005710.
51. Malhotra A.K., Pinals D.A., Adler C.M., Elman I., Clifton A., Pickar D., Breier A. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 1997, 17:141-150.
52. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., Schwalb J.M., Kennedy S.H. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
53. Moghaddam B., Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 1998, 281:1349-1352.
54. Murphy E.R., Dalley J.W., Robbins T.W. Local glutamate receptor antagonism in the rat prefrontal cortex disrupts response inhibition in a visuospatial attentional task. Psychopharmacology (Berl.) 2005, 179:99-107.
55. Murray J.D., Anticevic A., Gancsos M., Ichinose M., Corlett P.R., Krystal J.H., Wang X.J. Linking microcircuit dysfunction to cognitive impairment: effects of disinhibition associated with schizophrenia in a cortical working memory model. Cereb. Cortex 2012, Published online November 29, 2012. 10.1093/cercor/bhs370.
56. Paspalas C.D., Wang M., Arnsten A.F.T. Constellation of HCN Channels and cAMP regulating proteins in dendritic spines of the primate prefrontal cortex: potential substrate for working memory deficits in schizophrenia. Cereb. Cortex 2012, 2012:12.
57. Perlstein W.M., Carter C.S., Noll D.C., Cohen J.D. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am. J. Psychiatry 2001, 158:1105-1113.
58. Preuss T.M. Do rats have prefrontal cortex? The Rose-Woolsey-Akert program reconsidered. J. Cogn. Neurosci. 1995, 7:1-24.
59. Rao S.G., Williams G.V., Goldman-Rakic P.S. Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. J. Neurosci. 2000, 20:485-494.
60. Roberts B.M., Shaffer C.L., Seymour P.A., Schmidt C.J., Williams G.V., Castner S.A. Glycine transporter inhibition reverses ketamine-induced working memory deficits. Neuroreport 2010, 21:390-394.
61. Ross C.A., Margolis R.L., Reading S.A., Pletnikov M., Coyle J.T. Neurobiology of schizophrenia. Neuron 2006, 52:139-153.
62. Rotaru D.C., Yoshino H., Lewis D.A., Ermentrout G.B., Gonzalez-Burgos G. Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia. J. Neurosci. 2011, 31:142-156.
63. Rowland L.M., Bustillo J.R., Mullins P.G., Jung R.E., Lenroot R., Landgraf E., Barrow R., Yeo R., Lauriello J., Brooks W.M. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am. J. Psychiatry 2005, 162:394-396.
64. Rushworth M.F., Behrens T.E. Choice, uncertainty and value in prefrontal and cingulate cortex. Nat. Neurosci. 2008, 11:389-397.
65. Salvadore G., Cornwell B.R., Colon-Rosario V., Coppola R., Grillon C., Zarate C.A.J., Manji H.K. Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol. Psychiatry 2009, 65:289-295.
66. Sawaguchi T., Matsumura M., Kubota K. Depth distribution of neuronal activity related to a visual reaction time task in the monkey prefrontal cortex. J. Neurophysiol. 1989, 61:435-446.
67. Schroeter M.L., Vogt B., Frisch S., Becker G., Barthel H., Mueller K., Villringer A., Sabri O. Executive deficits are related to the inferior frontal junction in early dementia. Brain 2012, 135:201-215.
68. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry 1995, 52:805-818. discussion 819-820.
69. Seo H., Lee D. Behavioral and neural changes after gains and losses of conditioned reinforcers. J. Neurosci. 2009, 29:3627-3641.
70. Skoblenick K., Everling S. NMDA antagonist ketamine reduces task selectivity in macaque dorsolateral prefrontal neurons and impairs performance of randomly interleaved prosaccades and antisaccades. J. Neurosci. 2012, 32:12018-12027.
71. Skolnick P., Popik P., Trullas R. Glutamate-based antidepressants: 20 years on. Trends Pharmacol. Sci. 2009, 30:563-569.
72. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T.H., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., Greengard P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 2005, 8:1051-1058.
73. Sommer M.A., Wurtz R.H. Brain circuits for the internal monitoring of movements. Annu. Rev. Neurosci. 2008, 31:317-338.
74. Stefani M.R., Groth K., Moghaddam B. Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability. Behav. Neurosci. 2003, 117:728-737.
75. van Dyck C.H. Understanding the latest advances in pharmacologic interventions for Alzheimer's disease. CNS Spectr. 2004, 9(7, Suppl 5):24-28.
76. Verma A., Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J. Neurosci. 1996, 16:373-379.
77. Vijayraghavan S., Wang M., Birnbaum S.G., Williams G.V., Arnsten A.F.T. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat. Neurosci. 2007, 10:376-384.
78. Wallis J.D., Anderson K.C., Miller E.K. Single neurons in prefrontal cortex encode abstract rules. Nature 2001, 411:953-956.
79. Wang H., Stradtman G.G., Wang X.J., Gao W.J. A specialized NMDA receptor function in layer 5 recurrent microcircuitry of the adult rat prefrontal cortex. Proc. Natl. Acad. Sci. USA 2008, 105:16791-16796.
80. Wang M., Ramos B.P., Paspalas C.D., Shu Y., Simen A., Duque A., Vijayraghavan S., Brennan A., Dudley A.G., Nou E., et al. Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell 2007, 129:397-410.
81. Wang M., Vijayraghavan S., Goldman-Rakic P.S. Selective D2 receptor actions on the functional circuitry of working memory. Science 2004, 303:853-856.
82. Wang X.-J. Synaptic reverberation underlying mnemonic persistent activity. Trends Neurosci. 2001, 24:455-463.
83. Wang X.J. Synaptic basis of cortical persistent activity: the importance of NMDA receptors to working memory. J. Neurosci. 1999, 19:9587-9603.
84. Wang X.J. Probabilistic decision making by slow reverberation in cortical circuits. Neuron 2002, 36:955-968.
85. Weickert C.S., Fung S.J., Catts V.S., Schofield P.R., Allen K.M., Moore L.T., Newell K.A., Pellen D., Huang X.F., Catts S.V., Weickert T.W. Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia. Mol. Psychiatry 2012, Published online October 16, 2012. 10.1038/mp.2012.137.
86. Zarate C.A.J., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., Charney D.S., Manji H.K. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 2006, 63:856-864.